DocGo (DCGO) investor relations material

Key business highlights

• Focus on tech-driven mobile healthcare, expanding medical transportation, and care in the home, with a strong technology backbone integrated with Epic and athenahealth.

• Medical transportation business generated over $200 million in revenue, with U.S. trip volume up 17% year-over-year in Q1.

• Care in the home business grew 131% year-over-year, even excluding the SteadyMD acquisition, and patient monitoring serves 55,000 patients with 60% gross margins.

• Virtual health platform completed over 1 million telehealth visits in Q1, operating in all 50 states with over 3,000 clinical staff and 900+ vehicles.

• Patient net promoter score is 92, with strong partnerships with major hospital systems and insurers.

Financial performance and outlook

• Q1 revenue was $75.5 million, with no COVID or migrant-related revenue for the first time in years.

• Adjusted gross margin for the quarter was 31.6%, with an adjusted EBITDA loss of $10.2 million.

• Raised full-year revenue guidance to $300–$315 million, with expected adjusted EBITDA loss of $5–$10 million and a path to profitability in the back half of the year.

• No long-term debt and $60 million in cash on the balance sheet.

• Growth in Q1 included 17% increase in U.S. medical transportation, 46% in healthcare in the home, and 37% in virtual care and lab orders.

Strategic initiatives and differentiation

• Selected for CMS's ACCESS program, rewarding improved health outcomes and tech-supported care.

• Recognized as one of the world's most ethical companies and best healthcare cyber company.

• Proprietary tech platform enables efficient care delivery, leveraging AI for scheduling, billing, and clinical oversight.

• Unique model combines in-person, virtual, and remote care, with a focus on closing care gaps and managing chronic conditions.

• SteadyMD acquisition enhances telehealth capabilities and margin profile.